dihexa pnb-0408 c-met hgfr activator Activated HGF-c-Met Axis in Head and Neck Cancer Buy Dihexa – CAS 1401708-83-5
Buy Dihexa CAS 1401708 83 5 Rexar Drug development of MET inhibitors: targeting oncogene addiction and expedience Nature Reviews Drug Discovery HGF Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment PMC The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic dihexa peptide oral Neural Growth Factor Support in Central Florida: for Focus, Memory, and Stress Relief Dihexa (PNB 0408) c Met HGFR Activator Pancreatic Cancer Treatment Targeting the HGF c MET Pathway: The MEK Inhibitor Trametinib
Pay in 4 interest-free payments of $5.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14





